Reading Time: 3 minutesThe AMBRoSIA (A Multicentre Biomarker Resource Strategy In ALS) project is our biggest, most ambitious research undertaking to date. The project funding began in August,
Category: Markers of Disease Progression
Reading Time: 2 minutesMagnetic Resonance Imaging (MRI) technology is advancing rapidly as a tool for diagnosing and monitoring disease. In MND, MRI scans are used to understand changes
Reading Time: 2 minutesWhat are fasciculations? When motor neurones in the spinal cord become damaged this makes them electrically unstable, meaning they spontaneously discharge electrical impulses that cause
Reading Time: 3 minutesWhen diagnosing MND, it is important to look at the activity and impact of the motor neurones themselves – is the electrical message being carried
Reading Time: 2 minutesThere is a critical need to find a biomarker for MND to speed up diagnosis, monitor disease progression and improve clinical trials. A biomarker is
Reading Time: 3 minutesDeveloping a way to rapidly diagnose and track how MND progresses over time is a ‘holy grail’ of MND research. The search for so called
Reading Time: 2 minutesBiomarkers in Oxford (BioMOx) is a research project with the aim of identifying a diagnostic biomarker for MND, which could be used to track the
Reading Time: 3 minutesAt present there is no diagnostic test for MND, and diagnosis is usually determined through clinical observations and by excluding other diseases. Because of this,
Reading Time: 3 minutesSaturday afternoon saw the 25th International Symposium on ALS/MND expand from two to three sessions running in parallel. Times have changed from the early years of